baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Knock-Out 1FC/ DE000MG1LQ52 /

17/05/2024 12:19:51	Chg.+0.08	Bid17:30:04	Ask17:30:04	Underlying	Strike price	Expiration date	Option type
1.44EUR	+5.88%	- Bid Size: -	- Ask Size: -	FACC AG INH.AKT.	5.6351 EUR	31/12/2078	Call

GlobeNewswire 14:00 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine

GlobeNewswire 13:30 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...

GlobeNewswire 16/05 CVRx Announces Key Senior Leadership Team Hires

GlobeNewswire 15/05 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium

GlobeNewswire 15/05 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...

GlobeNewswire 07/05 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...

GlobeNewswire 07/05 Rugby Provides Exploration Update on its Gold-Silver Projects in Santa Cruz Province, Argentina

GlobeNewswire 02/05 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...

GlobeNewswire 30/04 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...

GlobeNewswire 23/04 Clinical ink announces GlucoseReady™

GlobeNewswire 08/04 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...

GlobeNewswire 07/04 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...

GlobeNewswire 01/04 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...

GlobeNewswire 27/03 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...

GlobeNewswire 25/03 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...

GlobeNewswire 25/03 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation

GlobeNewswire 13/03 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...

GlobeNewswire 12/03 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...

GlobeNewswire 27/02 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...

GlobeNewswire 26/02 HeartSciences Adds Key Advisor to its Scientific Advisory Board

GlobeNewswire 22/02 RAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTS

GlobeNewswire 20/02 Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...

GlobeNewswire 09/02 Inteleos Announces 2024 Board of Directors

GlobeNewswire 07/02 Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...

GlobeNewswire 29/01 Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...

Morgan Stanley Knock-Out 1FC/ DE000MG1LQ52 /

If you wish to receive reply to your feedback, please provide your email address.